Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: an Integrated MHealth Approach
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program designed to help women in Brazil quit smoking. It combines support from trained community health workers with a mobile app that provides additional resources and encouragement for quitting tobacco. The goal is to make this program culturally relevant and tailored specifically for women, particularly those from low-income backgrounds. Researchers will first test the program to see how well it works and if it's easy to use, then they will compare it to an existing program that includes home visits from community health workers.
To participate, women must be at least 18 years old, currently smoke tobacco, and be willing to try to quit. There are no specific health issues that would exclude someone from joining. If you take part, you can expect support from both a community health worker and through the mobile app, which will help track your progress and provide motivation. If this new approach proves effective, it could serve as a model for similar programs in other communities, including those in the U.S.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age
- • Current tobacco use
- • Willingness to quit tobacco use
- • resident in the town assigned to intervention or control
- Exclusion Criteria:
- • None
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Londrina, Paraná, Brazil
Londrina, , Brazil
Patients applied
Trial Officials
Isabel C Scarinci, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials